https://www.selleckchem.com/products/int-777.html
Epstein-Barr virus (EBV), an oncogenic human gammaherpesvirus, is associated with a wide range of human malignancies of epithelial and B-cell origin. Recent studies have demonstrated promising safety and clinical efficacy of allogeneic 'off-the-shelf' virus-specific T-cell therapies for post-transplant viral complications. Taking a clue from these studies, we developed a highly efficient EBV-specific T-cell expansion process using a ****tion-deficient AdE1-LMPpoly vector that specifically targets EBV-encoded nuclear antigen 1 (EBNA1)
처럼
논평
공유하다
